View Document Preview and Link Document Date: 2011-07-07 22:12:16 Open Document File Size: 449,27 KB Share Result on Facebook
City Chichester / New York / / Company John Wiley & Sons Ltd. / Safe Storage and Transport / / Continent America / / Country Germany / France / Australia / United Kingdom / / Event Product Issues / FDA Phase / Product Recall / / Facility Australian Institute of Health / Cochrane Library / / Holiday Commonwealth Day of Australia / / IndustryTerm family networks / prevention of HIV / treatment services / pharmacotherapy services / combination product / law enforcement / / MedicalCondition loss of consciousness / Hepatitis A / HIV / Drug Dependence Drug dependence / Hepatitis C / Drug Dependence / opioid dependence syndrome / characteristic withdrawal syndrome / mental disorders / HIV infection / heroin users / pain / heroin withdrawal symptoms / Heroin Addiction / HIV/AIDS / withdrawal symptoms / strong withdrawal symptoms / Heroin Dependence / / MedicalTreatment pharmacotherapies / adjunctive therapy / pharmacotherapy / / Organization Intergovernmental Committee on Drugs / National Expert Advisory Committee on Illicit Drugs / Therapeutic Goods Administration / Australian Government / Australian Institute of Health and Welfare / Department of Health / Victorian Department of Human Services / / Person Drug / Aboriginal Strait / Torres Strait / Allan Quigley / Bruce Wight / Chris Boag / Lynne Biggs / Aboriginal Strait Islander / Bob Batey / Robert Ali / Jeremy Hayllar / Torres Strait Islander / / Position Professor / Chair / Associate Professor / / Product symptoms / Schedule 8 / Subutex / ReVia / Naltrexone tablet / naloxone / Suboxone / Naltrexone Treatment Opioid Withdrawal Treatment Naltrexone Relapse Prevention Treatment Medication / agent / Buprenorphine / Methadone / Naltrexone Treatment Opioid / / Region South Australia / South Wales / / URL http / SocialTag 
NATIONAL PHARMACOTHERAPY POLICY For people dependent on opioids